We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Luminex Signs Development and Supply Agreement with Fisher HealthCare

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Luminex Corporation has announced the signing of a development and supply agreement with Fisher HealthCare, part of Thermo Fisher Scientific Inc. 

The agreement will provide Fisher HealthCare with access to Luminex xMAP® -based technology in the U.S. and offers Luminex a broad customer sales channel for xMAP-based instruments and assays.

Luminex and Fisher HealthCare will jointly identify promising molecular diagnostic applications for Luminex to develop and manufacture on behalf of Fisher HealthCare, taking advantage of the assay multiplexing capabilities of Luminex's xMAP technology.

Fisher HealthCare is a channel to laboratory customers in the United States, with a multi- layered sales force, access to key clinical accounts and a logistics network.

Specific terms of the agreement were not disclosed.